What is Burzynski Research?
engages in the research and development of antineoplaston drugs for the treatment of various cancers.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.77M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.